Aerosol generation from propellant-driven metered dose inhalers

Inhalation Aerosols: Physical and Biological Basis for Therapy

Volumn , Issue , 2006, Pages 399-416

  Smyth, Hugh D C ^a   Hickey, Anthony J ^b   Evans, Richard M ^c  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57749199983     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (71)

1. Riker Laboratories, I., Self-propelling, powder-dispensing compositions. US Patent # 837,465. 1960.
2. Masters K. Drying of droplets/sprays. In: Spray Drying Handbook. 5th ed. Longman Scientific and Technical, New York, NY 1993:309-352.
3. Seaver M, et al. Evaporation kinetics of ventilated waterdrops coated with octadecanol monolayers. J Phys Chem 1992; 96:6389-6394.
4. Hickey AJ. Aerosol filling equipment for the preparation of pressurized pack pharmaceutical formulations. In: Hickey A.J, ed. Pharmaceutical Inhalation Aerosol Technology. NY: Marcel Dekker, 2004:311-343.
5. Smyth HD. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv Drug Deliv Rev 2003; 55(7):807-828.
6. Finlay WH. The Mechanics of Inhaled Pharmaceutical Aerosols. London: Academic Press, 2001.
7. Domnick J, Durst F. Measurement of bubble size, velocity and concentration in flashing flow behind a sudden constriction. Int J Multiphase Flow 1995; 21:1047-1062.
8. Dunbar CA, Watkins A.P, Miller JF. Theoretical investigation of the spray from a pressurized metered-dose inhaler. Atomization Sprays 1997; 7(4):417-436.
9. Dunbar CA, Watkins A.P, Miller JF. An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. J Aerosol Med 1997; 10(4):351-368.
10. Hallworth GW. The formulation and evaluation of metered dose inhalers. In: Ganderton D, Jones TM, eds. Drug Delivery to the Respiratory Tract. NY: VCH Publishers, 1987.
11. Gabrio BJ, SWV Stein DJ. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. International Journal of Pharmaceutics, 1999; 186(1):3-12.
12. Crank J. The Mathematics of Diffusion. 2d ed. Oxford: Oxford Science Publications, 1975.
13. Prandtl L, Tiejens OG. Fundamentals of Hydro- and Aeromechanics. Mineola, NY: Dover Publications, 1957 (Vol. reprinted from 1934).
14. Tovbin YK. Theory of Physical Chemistry Processes at Gas-Solid Interfaces. Boca Raton, FL: CRC Press, 1991.
15. Brown PH, et al. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax 1990; 45(10):736-739.
16. Kraemer R. Babyhaler-a new paediatric aerosol device. J Aerosol Med 1995; 8(suppl 2):S19-S26.
17. Newman SP, et al. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax 1984; 39(12):935-941.
18. Svartengren K, et al. Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics. Am J Respir Crit Care Med 1995; 152(1):32-37.
19. Lawford P, McKenzie D. Pressurized bronchodilator aerosol technique: influence of breath holding time and relationship of inhaler to mouth. Br J Dis Chest 1982; 76:229.
20. Smyth HDC, et al. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers. AAPS PharmSciTech 2004; 5(1):Article 7.
21. Dunbar CA. Atomization mechanisms of the pressurized metered dose inhaler. Part Sci Technol 1998; 15(3-4):253-271.
22. Dunbar CA, Hickey AJ. pMDI optimization using an actuator flow model. In: Respiratory Drug Delivery VIII, Davis Horwood International, Centennial, CO, 1998.
23. Lefebvre AH. Atomization and Sprays. In: Chigier N, ed. Combustion: An International Series. Taylor and Francis, Levitton, PA, 1989.
24. Carey VP. Convective boiling in tubes and channels. In: Liquid-Vapor Phase Change Phenomena. Hemisphere, Philadelphia, 1992:483-564.
25. Benjamin EJ, Kroeten JJ, Shek E. Characterization of spray patterns of inhalation aerosols using thin-layer chromatography. J Pharm Sci 1983; 72:380-385.
26. Smyth HD, et al. Spray pattern analysis for metered dose inhalers I: orifice size, particle size, and droplet motion correlations. Drug Development and Industrial Pharmacy. 2006; 32:1-9
27. Smyth HDC, et al. Correlation of spray patterns with droplet size for pressurized metered dose inhalers. Annual Meeting of American Association of Pharmaceutical Sciences, Toronto, Canada, AAPS Press, Arlington, VA, Nov 2002.
28. Dalby RN, Byron PR. Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions. Pharm Res, 1988; 5(1):36-39.
29. Chan HK, Gonda I. Development of a systematic theory of suspension inhalation aerosols. Part 2. Aggregates of monodisperse particles nebulized in polydisperse droplets. International Journal of Pharmaceutics 1988; 41:147-157.
30. Gonda I. Development of a systematic theory of suspension inhalation aerosols. I. A framework to study the effects of aggregation on the aerodynamic behaviour of drug particles. Int J Pharm 1985; 27:99-116.
31. Ranucci JA, et al. Controlled flocculation in metered-dose aerosol suspensions. Pharm Technol, 1990; 14(4):68, 70-72, 74.
32. Vervaet C, Byron PR. Drug-surfactant-propellant interactions in HFA-formulations. Int J Pharm 1999; 186(1):13-30.
33. Kertes AS, Gutman H. Surfactants in Organic Solvents: the physical chemistry of aggregation and micellization, In: Matijevic E, ed. Surface and Colliod Science. Wiley: NY, 1986:267-270.
34. Sommerville M, Hickey AJ. Microemulsion alternate propellant systems for aerosol drug delivery. In: Respiratory Drug Delivery VI, Interpharm, Buffalo Grove, IL,1998:421-424.
35. Evans RM, et al. A Novel strategy for the formulations of medicinal aerosols. J Aerosol Sci 1989; 20:1309.
36. Evans RM, et al. Size, shape and solubilizing potential of lecithin micelles in a model chlorofluo-rocarbon system. J Pharm Pharmacol 1989; 41:3P.
37. Clarke JG, Wicks SR, Farr SJ. Surfactant mediated effects in pressurized metered dose inhalers formulated as suspensions. Part 1. Drug/surfactant interactions in a model propellant system. International Journal of Pharmaceutics 1993; 93(May 31):221-231.
38. Hickey AJ, Dalby RN, Byron PR. Effects of surfactants on aerosol powders in suspension: implications for airborne particle size. International Journal of Pharmaceutics 1988; 42(Mar): 267-270.
39. Fuks GI, Tikhonov VP, Lebedev RA. Investigation of micelle formation by surfactants in nonpolar liquids by means of IR spectroscopy, 1. Solutions of Fatty acids in carbon tetrachloride. Russian Colloid J 1982; 44:77-82.
40. Tikhonov VP, Lebedev RA, Fuks GI. Investigation of micelle formation by surfactants in nonpolar liquids by means of IR spectroscopy, 2. Solutions of aliphatic alcohols in carbon tetrachloride. Russian Colloid J 1982; 44:57-61.
41. ™ in Therapeutic Drug Carrier Systems 2006; 22(6):493-534.
42. Stefely JS, et al. Surfactants designed for HFA-based MDIs. Abstracts of Papers, 224th ACS National Meeting, Boston, MA, Aug 18-22, 2002:COLL-322.
43. Rogueda P. Novel hydrofluoroalkane suspension formulations for respiratory drug delivery. Expert Opinion on Drug Delivery 2005; 2(4):625-638.
44. Byron PR, et al. Some aspects of alternative propellant solvency. In: Respiratory Drug Delivery IV, Interpharm Press, Buffalo Grove, IL 1994.
45. Meakin B, et al, Countering challenges posed by mimicry of CFC performance using HFA systems. In: Respiratory Drug Delivery VII, Serentec Press, Raleigh NC, 2000.
46. Gupta A, Stein SW, Myrdal PB. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers. J Aerosol Med 2003; 16(2):167-174.
47. Smyth HDC, Mejia-Millan EA, Hickey AJ. The effect of ethanol on solvency vapor pressure, and emitted droplet size of solution metered dose inhalers containing HFA 134a. Respir. Drug Delivery VIII 2002; 2:735-738.
48. Ganderton D, et al. The formulation and evaluation of a CFC-free budesonide pressurised metered dose inhaler. Respir Med 2003; 97(suppl D):S4-S9.
49. Ganderton D, et al. Modulite: a means of designing the aerosols generated by pressurized metered dose inhalers. Respir Med 2002; 96(suppl D):S3-S8.
50. Dalby RN, Phillips EM, Byron PN. Determination of drug solubility in aerosol propellants. Pharm Res 1991; 8(9):1206-1209.
51. Williams III, RO, Rogers TL, Liu J. Study of solubility of steroids in hydrofluoroalkane propellants. Drug Development & Industrial Pharmacy 1999; 25(12):1227-1234.
52. Gupta A, Myrdal PB, Novel method for the determination of solubility in aerosol propellants. J Pharm Sci 2004; 93(10):2411-2419.
53. Tzou T-Z. Density, excess molar volume, and vapor pressure of propellant mixtures in metered-dose inhalers: deviation from ideal mixtures. In: Respiratory Drug Delivery VI, Interpharm, Buffalo Grove, IL, 1998:439-443.
54. Williams III, RO, Repka M, Liu J. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler. Drug Dev Ind Pharm 1998; 24(8):763-770.
55. Zhu MS, Fu YD, Han LZ. Experimental study on vapor pressure of HFC-134a. J Therm Sci 1992; 1(2):80-82.
56. Evans RM, et al. Formulation and In-Vitro Evaluation of Pressurized Inhalation Aerosols containing Isotropic Systems of Lecithin and Water. Pharm Res 1991; 8:629-635.
57. Johnson KA. Interfacial phenomena and phase behavior in metered-dose inhaler formulations. Lung Biol Health Dis 1996; 94(Inhalation Aerosols):385-415.
58. Berry J, et al. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler. Drug Dev Ind Pharm 2004; 30(3):267-275.
59. Cummings RH. Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition-valve performance. J Allergy Clin Immunol 1999; 104(6):S230-S236.
60. Mahon G, et al. The consistent delivery valve for metered dose inhalers. In: Respiratory Drug Delivery VIII, Davis Horwood International, Centennial, CO, 2002.
61. Tiwari D, et al. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant. Drug Dev Ind Pharm 1998; 24(4):345-352.
62. Hickey AJ, Quigley K, Evans R. Spray formation at the actuator of a metered dose inhaler. Pharm Res 1993; 10:S137.
63. McCabe WL, Smith JC, Harriot P. Unit Operations of Chemical Engineering. New York: McGraw-Hill, 1985.
64. Hinds WC. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. Vol. XX. 2d ed. New York: Wiley. 1999:483.
65. Perry RH, Green D. Perry's Chemical Engineers' Handbook. NY: McGraw-Hill, 1997.
66. Martin A. Physical Pharmacy. 4th ed. Philidephia: Lippincott Williams and Wilkins, 1993.
67. Bird RB, Stewart WE, Lightfoot EN. Transport Phenomena. NY: Wiley, 1960.
68. Clark AR. Metered atomization for respiratory drug delivery. Loughborough University of Technology, U.K., 1991.
69. Byron PR. Towards the rational formulation of metered dose inhalers. J Biopharm Sci 1992; 3(1-2):1-9.
70. Newman SP, et al. The effects of changes in metered volume and propellant vapor pressure on the deposition of pressurized inhalation aerosols. Int J Pharm 1982; 11(4):337-344.
71. Dolovich M. Lung dose, distribution, and clinical response to therapeutic aerosols. Aerosol Sci Technol 1993: 18:230-240.